Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

All categories

DBCAT003359Therapeutic category

A DrugBank category of 10 drugs. 8 of them are approved.

Drugs: Abacavir
Abacavir hydroxyacetate
Didanosine
Emtricitabine
Lamivudine
Stavudine
Tenofovir
Tenofovir alafenamide
Tenofovir disoproxil
Zidovudine

What you can answer from here — as of October 25, 2017

10DrugsEach linked to its full drug card

Listed above

12Drug targetsEvery drug–target pair in the class, with bond type

1,921Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account